申请人:CHIESI FARMACEUTICI S.P.A.
公开号:US20170183345A1
公开(公告)日:2017-06-29
Compounds of formula (I) defined herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
根据此处定义的公式(I)化合物是p38
MAPK
抑制剂,并且作为抗炎剂在治疗呼吸道疾病等方面是有用的。